{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:53Z","timestamp":1792787873775,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Foundation for Advanced Talents of Fujian Medical University","award":["XN240017"],"award-info":[{"award-number":["XN240017"]}],"id":[{"id":"https:\/\/ror.org\/050s6ns64","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Fujian Province of China","award":["2025J01706"],"award-info":[{"award-number":["2025J01706"]}]},{"name":"Fujian Provincial Natural Science Foundation of China","award":["2025J011164"],"award-info":[{"award-number":["2025J011164"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2025QNA052"],"award-info":[{"award-number":["2025QNA052"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16369-5","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:05:24Z","timestamp":1782450324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of pretreatment pan-immune inflammation value in esophageal squamous cell carcinoma patients undergoing definitive chemoradiotherapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Yibin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"10466","key":"16369_CR1","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(24)02226-8","volume":"404","author":"H Yang","year":"2024","unstructured":"Yang H, Wang F, Hallemeier CL, Lerut T, Fu J. Oesophageal cancer. Lancet. 2024;404(10466):1991\u20132005.","journal-title":"Lancet"},{"issue":"1","key":"16369_CR2","first-page":"e70043","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026;76(1):e70043.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"16369_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","volume":"21","author":"JA Ajani","year":"2023","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P, et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21(4):393\u2013422.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"16369_CR4","doi-asserted-by":"publisher","first-page":"100789","DOI":"10.1016\/j.esmoop.2023.100789","volume":"8","author":"HC Puhr","year":"2023","unstructured":"Puhr HC, Prager GW, Ilhan-Mutlu A. How we treat esophageal squamous cell carcinoma. ESMO Open. 2023;8(1):100789.","journal-title":"ESMO Open"},{"issue":"9","key":"16369_CR5","doi-asserted-by":"publisher","first-page":"110296","DOI":"10.1016\/j.ejso.2025.110296","volume":"51","author":"S Wu","year":"2025","unstructured":"Wu S, Ye M, Zhang G, Dai L, Wang Z, Yu Y, et al. Tumor deposits in the impact of esophageal squamous cell carcinoma prognosis and recurrence: A multicenter retrospective cohort study. Eur J Surg Oncol. 2025;51(9):110296.","journal-title":"Eur J Surg Oncol"},{"key":"16369_CR6","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"16369_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s42255-025-01287-w","volume":"7","author":"A Nobels","year":"2025","unstructured":"Nobels A, van Marcke C, Jordan BF, Van Hul M, Cani PD. The gut microbiome and cancer: from tumorigenesis to therapy. Nat Metab. 2025;7(5):895\u2013917.","journal-title":"Nat Metab"},{"issue":"15","key":"16369_CR8","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1097\/CM9.0000000000001775","volume":"135","author":"X Liu","year":"2022","unstructured":"Liu X, Jiang Q, Shen S, Hou Y. Local and systemic inflammation triggers different outcomes of tumor growth related to infiltration of anti-tumor or pro-tumor macrophages. Chin Med J (Engl). 2022;135(15):1821\u20138.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"16369_CR9","doi-asserted-by":"publisher","first-page":"7316","DOI":"10.1038\/s41467-022-35096-6","volume":"13","author":"Q Sui","year":"2022","unstructured":"Sui Q, Zhang X, Chen C, Tang J, Yu J, Li W, et al. Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer. Nat Commun. 2022;13(1):7316.","journal-title":"Nat Commun"},{"issue":"6","key":"16369_CR10","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1245\/s10434-021-09640-5","volume":"28","author":"AE Kam","year":"2021","unstructured":"Kam AE, Masood A. The Prognostic Role of the Neutrophil to Lymphocyte Ratio at Recurrence in Esophageal Squamous Cell Carcinoma: Challenges and Future Directions. Ann Surg Oncol. 2021;28(6):2939\u201340.","journal-title":"Ann Surg Oncol"},{"key":"16369_CR11","doi-asserted-by":"publisher","first-page":"111863","DOI":"10.1016\/j.intimp.2024.111863","volume":"131","author":"ZY Wang","year":"2024","unstructured":"Wang ZY, Xu B, Wang LN, Zhu XD, Huang C, Shen YH, et al. Platelet-to-lymphocyte ratio predicts tumor response and survival of patients with hepatocellular carcinoma undergoing immunotherapies. Int Immunopharmacol. 2024;131:111863.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"16369_CR12","doi-asserted-by":"publisher","first-page":"29500","DOI":"10.1038\/s41598-025-15309-w","volume":"15","author":"K Wang","year":"2025","unstructured":"Wang K, Li K, Zhang Z, Zeng X, Wu Z, Zhang B, et al. Combined preoperative platelet-albumin ratio and cancer inflammation prognostic index predicts prognosis in colorectal cancer: a retrospective study. Sci Rep. 2025;15(1):29500.","journal-title":"Sci Rep"},{"issue":"1","key":"16369_CR13","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1186\/s12885-025-15165-x","volume":"25","author":"K Li","year":"2025","unstructured":"Li K, Zhang R, Zhang J, Zhang Z, Wang K, Lu Y, et al. The prognostic role of inflammation-based hematologic markers in stage I-III colorectal cancer: a retrospective analysis. BMC Cancer. 2025;25(1):1822.","journal-title":"BMC Cancer"},{"key":"16369_CR14","doi-asserted-by":"publisher","first-page":"1694587","DOI":"10.3389\/fonc.2025.1694587","volume":"15","author":"K Wang","year":"2025","unstructured":"Wang K, Zhang B, Li K, Zhang Z, Zeng X, Guan JM, et al. Novel immune-nutritional prognostic ratio predicts long-term survival in stage I-III colorectal cancer. Front Oncol. 2025;15:1694587.","journal-title":"Front Oncol"},{"issue":"97","key":"16369_CR15","doi-asserted-by":"publisher","first-page":"eadk3981","DOI":"10.1126\/sciimmunol.adk3981","volume":"9","author":"G Dunsmore","year":"2024","unstructured":"Dunsmore G, Guo W, Li Z, Bejarano DA, Pai R, Yang K, et al. Timing and location dictate monocyte fate and their transition to tumor-associated macrophages. Sci Immunol. 2024;9(97):eadk3981.","journal-title":"Sci Immunol"},{"issue":"1","key":"16369_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12943-024-02064-1","volume":"23","author":"X Chu","year":"2024","unstructured":"Chu X, Tian Y, Lv C. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages. Mol Cancer. 2024;23(1):150.","journal-title":"Mol Cancer"},{"issue":"14","key":"16369_CR17","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1021\/acsnano.3c01428","volume":"17","author":"J Kuang","year":"2023","unstructured":"Kuang J, Rao ZY, Zheng DW, Kuang D, Huang QX, Pan T, et al. Nanoparticles Hitchhike on Monocytes for Glioblastoma Treatment after Low-Dose Radiotherapy. ACS Nano. 2023;17(14):13333\u201347.","journal-title":"ACS Nano"},{"issue":"2","key":"16369_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/cas.16400","volume":"116","author":"Q Wang","year":"2025","unstructured":"Wang Q, Zhong W, Xiao Y, Lin G, Lu J, Xu L, et al. Pan-immune-inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer. Cancer Sci. 2025;116(2):350\u201366.","journal-title":"Cancer Sci"},{"key":"16369_CR19","doi-asserted-by":"publisher","unstructured":"Dursun B, Demir B, Oksuz NE, Soydal C, Utkan G. TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer. J Clin Med. 2025;14(14). https:\/\/doi.org\/10.3390\/jcm14144927.","DOI":"10.3390\/jcm14144927"},{"key":"16369_CR20","doi-asserted-by":"publisher","first-page":"1036890","DOI":"10.3389\/fonc.2022.1036890","volume":"12","author":"XC Yang","year":"2022","unstructured":"Yang XC, Liu H, Liu DC, Tong C, Liang XW, Chen RH. Prognostic value of pan-immune-inflammation value in colorectal cancer patients: A systematic review and meta-analysis. Front Oncol. 2022;12:1036890.","journal-title":"Front Oncol"},{"issue":"1","key":"16369_CR21","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.1038\/s41598-022-10884-8","volume":"12","author":"M Perez-Martelo","year":"2022","unstructured":"Perez-Martelo M, Gonzalez-Garcia A, Vidal-Insua Y, Blanco-Freire C, Brozos-Vazquez EM, Abdulkader-Nallib I, et al. Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy. Sci Rep. 2022;12(1):6893.","journal-title":"Sci Rep"},{"key":"16369_CR22","doi-asserted-by":"publisher","first-page":"724443","DOI":"10.3389\/fimmu.2021.724443","volume":"12","author":"R Zeng","year":"2021","unstructured":"Zeng R, Liu F, Fang C, Yang J, Luo L, Yue P, et al. PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1\/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients. Front Immunol. 2021;12:724443.","journal-title":"Front Immunol"},{"issue":"1","key":"16369_CR23","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1186\/s12885-023-11366-4","volume":"23","author":"Y Chen","year":"2023","unstructured":"Chen Y, Gong L, Gu P, Hua Y, Sun Y, Ni S, et al. Pan-immune-inflammation and its dynamics: predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy. BMC Cancer. 2023;23(1):944.","journal-title":"BMC Cancer"},{"key":"16369_CR24","doi-asserted-by":"publisher","first-page":"1802591","DOI":"10.3389\/fmed.2026.1802591","volume":"13","author":"M Wang","year":"2026","unstructured":"Wang M, Wang J, Wang X, Li J, Hu Y, Ji H, et al. Pan-immune-inflammation value is a novel prognostic biomarker in pT2-4 gastric cancer. Front Med (Lausanne). 2026;13:1802591.","journal-title":"Front Med (Lausanne)"},{"key":"16369_CR25","doi-asserted-by":"publisher","unstructured":"Senocak D, Karakullukcu M, Ozkan E, Bilgi O, Ozgun MA. Prognostic significance of the pan-immune-inflammatory value (PIV) in gastric cancer: a retrospective cohort study. BMC Cancer. 2026;26(1). https:\/\/doi.org\/10.1186\/s12885-026-15759-z.","DOI":"10.1186\/s12885-026-15759-z"},{"key":"16369_CR26","doi-asserted-by":"publisher","first-page":"175883592311937","DOI":"10.1177\/17588359231193732","volume":"15","author":"ML Gasparri","year":"2023","unstructured":"Gasparri ML, Albasini S, Truffi M, Favilla K, Tagliaferri B, Piccotti F, et al. Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis. Ther Adv Med Oncol. 2023;15:17588359231193732.","journal-title":"Ther Adv Med Oncol"},{"key":"16369_CR27","doi-asserted-by":"publisher","unstructured":"Sahin TK, Akyildiz A, Dogan OT, Kavgaci G, Guven DC, Aksoy S. Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine. Pharmaceuticals (Basel). 2024;17(7). https:\/\/doi.org\/10.3390\/ph17070824.","DOI":"10.3390\/ph17070824"},{"key":"16369_CR28","doi-asserted-by":"publisher","first-page":"110738","DOI":"10.1016\/j.cellsig.2023.110738","volume":"109","author":"S Patrick","year":"2023","unstructured":"Patrick S, Lathoria K, Suri V, Sen E. Reduced YAP1 and FOLR1 in gliomas predict better response to chemotherapeutics. Cell Signal. 2023;109:110738.","journal-title":"Cell Signal"},{"key":"16369_CR29","doi-asserted-by":"publisher","first-page":"1040163","DOI":"10.3389\/fphar.2022.1040163","volume":"13","author":"Y Wen","year":"2022","unstructured":"Wen Y, Zhu Y, Zhang C, Yang X, Gao Y, Li M, et al. Chronic inflammation, cancer development and immunotherapy. Front Pharmacol. 2022;13:1040163.","journal-title":"Front Pharmacol"},{"issue":"2","key":"16369_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41416-022-01775-w","volume":"127","author":"SM Afify","year":"2022","unstructured":"Afify SM, Hassan G, Seno A, Seno M. Cancer-inducing niche: the force of chronic inflammation. Br J Cancer. 2022;127(2):193\u2013201.","journal-title":"Br J Cancer"},{"issue":"3","key":"16369_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41416-020-0894-7","volume":"123","author":"G Fuca","year":"2020","unstructured":"Fuca G, Guarini V, Antoniotti C, Morano F, Moretto R, Corallo S, et al. The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials. Br J Cancer. 2020;123(3):403\u20139.","journal-title":"Br J Cancer"},{"key":"16369_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejca.2021.03.043","volume":"150","author":"F Corti","year":"2021","unstructured":"Corti F, Lonardi S, Intini R, Salati M, Fenocchio E, Belli C, et al. The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors. Eur J Cancer. 2021;150:155\u201367.","journal-title":"Eur J Cancer"},{"issue":"1","key":"16369_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1182\/bloodadvances.2021005721","volume":"6","author":"C Brings","year":"2022","unstructured":"Brings C, Frobel J, Cadeddu P, Germing U, Haas R, Gattermann N. Impaired formation of neutrophil extracellular traps in patients with MDS. Blood Adv. 2022;6(1):129\u201337.","journal-title":"Blood Adv"},{"issue":"19","key":"16369_CR34","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.1021\/acs.jafc.2c01329","volume":"70","author":"H Zhu","year":"2022","unstructured":"Zhu H, Yu Q, Ouyang H, Zhang R, Li J, Xian R, et al. Antagonistic Effect of Selenium on Fumonisin B1 Promotes Neutrophil Extracellular Traps Formation in Chicken Neutrophils. J Agric Food Chem. 2022;70(19):5911\u201320.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"16369_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12964-023-01440-6","volume":"22","author":"H Zhang","year":"2024","unstructured":"Zhang H, Wu D, Wang Y, Shi Y, Shao Y, Zeng F, et al. Ferritin-mediated neutrophil extracellular traps formation and cytokine storm via macrophage scavenger receptor in sepsis-associated lung injury. Cell Commun Signal. 2024;22(1):97.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"16369_CR36","doi-asserted-by":"publisher","first-page":"e1702","DOI":"10.1002\/wnan.1702","volume":"13","author":"M Geranpayehvaghei","year":"2021","unstructured":"Geranpayehvaghei M, Dabirmanesh B, Khaledi M, Atabakhshi-Kashi M, Gao C, Taleb M, et al. Cancer-associated-platelet-inspired nanomedicines for cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;13(5):e1702.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"16369_CR37","doi-asserted-by":"publisher","first-page":"109718","DOI":"10.1016\/j.biopha.2019.109718","volume":"123","author":"L Sun","year":"2020","unstructured":"Sun L, Li Q, Guo Y, Yang Q, Yin J, Ran Q, et al. Extract of Caulis Spatholobi, a novel platelet inhibitor,efficiently suppresses metastasis of colorectal cancer by targeting tumor cell-induced platelet aggregation. Biomed Pharmacother. 2020;123:109718.","journal-title":"Biomed Pharmacother"},{"key":"16369_CR38","doi-asserted-by":"publisher","first-page":"115612","DOI":"10.1016\/j.bcp.2023.115612","volume":"213","author":"Z Song","year":"2023","unstructured":"Song Z, Wang X, Liu X, Luo Y, Qiu J, Yin A, et al. Targeting of Annexin A1 in Tumor-associated Macrophages as a therapeutic strategy for hepatocellular carcinoma. Biochem Pharmacol. 2023;213:115612.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"16369_CR39","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.7150\/ijbs.95463","volume":"20","author":"SL Lin","year":"2024","unstructured":"Lin SL, Yang SY, Tsai CH, Fong YC, Chen WL, Liu JF, et al. Nerve growth factor promote VCAM-1-dependent monocyte adhesion and M2 polarization in osteosarcoma microenvironment: Implications for larotrectinib therapy. Int J Biol Sci. 2024;20(11):4114\u201327.","journal-title":"Int J Biol Sci"},{"key":"16369_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.semcdb.2020.12.002","volume":"115","author":"L Kaschek","year":"2021","unstructured":"Kaschek L, Zophel S, Knorck A, Hoth M. A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity. Semin Cell Dev Biol. 2021;115:10\u20138.","journal-title":"Semin Cell Dev Biol"},{"issue":"6591","key":"16369_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1126\/science.abl3855","volume":"376","author":"AT Ritter","year":"2022","unstructured":"Ritter AT, Shtengel G, Xu CS, Weigel A, Hoffman DP, Freeman M, et al. ESCRT-mediated membrane repair protects tumor-derived cells against T cell attack. Science. 2022;376(6591):377\u201382.","journal-title":"Science"},{"issue":"1","key":"16369_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12964-024-01718-3","volume":"22","author":"S Shouman","year":"2024","unstructured":"Shouman S, El-Kholy N, Hussien AE, El-Derby AM, Magdy S, Abou-Shanab AM, et al. SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147. Cell Commun Signal. 2024;22(1):349.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"16369_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TGFbeta biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2021;18(1):9\u201334.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"16369_CR44","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ccell.2025.03.030","volume":"43","author":"L Cheng","year":"2025","unstructured":"Cheng L, Zhang Y, Cell death. IL-1 cytokines, and tumor progression. Cancer Cell. 2025;43(5):817\u20139.","journal-title":"Cancer Cell"},{"issue":"1","key":"16369_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct Target Ther. 2024;9(1):176.","journal-title":"Signal Transduct Target Ther"},{"key":"16369_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cyto.2018.03.020","volume":"108","author":"C Tan","year":"2018","unstructured":"Tan C, Hu W, He Y, Zhang Y, Zhang G, Xu Y, et al. Cytokine-mediated therapeutic resistance in breast cancer. Cytokine. 2018;108:151\u20139.","journal-title":"Cytokine"},{"issue":"1","key":"16369_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41746-025-02268-9","volume":"9","author":"S Chen","year":"2026","unstructured":"Chen S, Ding P, Yang Y, Ma S, Guo H, Han X, et al. Multimodal digital biopsy for preoperative prediction of occult peritoneal metastasis in gastric cancer. NPJ Digit Med. 2026;9(1):107.","journal-title":"NPJ Digit Med"},{"key":"16369_CR48","doi-asserted-by":"publisher","unstructured":"Ding P, Chen S, Guo H, Yang S, Wang X, Han X et al. A deep learning-based digital biopsy for predicting early recurrence in gastric cancer. Nat Commun. 2026. https:\/\/doi.org\/10.1038\/s41467-026-71347-6.","DOI":"10.1038\/s41467-026-71347-6"},{"issue":"43","key":"16369_CR49","doi-asserted-by":"publisher","first-page":"e08190","DOI":"10.1002\/advs.202508190","volume":"12","author":"P Ding","year":"2025","unstructured":"Ding P, Yang J, Chen S, Guo H, Wu J, Wu H, et al. Interpretable Multimodal Fusion Model Enhances Postoperative Recurrence Prediction in Gastric Cancer. Adv Sci (Weinh). 2025;12(43):e08190.","journal-title":"Adv Sci (Weinh)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16369-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16369-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16369-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:05:07Z","timestamp":1789754707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16369-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16369"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16369-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by Fujian Cancer Hospital\u2019s Ethics Committee. All patients provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1118"}}